Gonorrhea (Neisseria gonorrhoeae)
Overview
Plain-Language Overview
Gonorrhea is a common sexually transmitted infection caused by the bacterium Neisseria gonorrhoeae. It primarily affects the genital tract, but can also involve the rectum, throat, and eyes. The infection often causes symptoms like painful urination and abnormal discharge, but many people may have no symptoms at all. If untreated, it can lead to serious health problems such as pelvic inflammatory disease in women and infertility in both sexes. The infection spreads through sexual contact and can be passed from mother to baby during childbirth.
Clinical Definition
Gonorrhea is an acute mucosal infection caused by the gram-negative diplococcus Neisseria gonorrhoeae. It primarily infects the urogenital epithelium, but can also involve the rectal, pharyngeal, and conjunctival mucosa. The pathogen adheres to and invades epithelial cells using pili and outer membrane proteins, evading host immune responses. Clinically, it presents with urethritis, cervicitis, or proctitis, and can disseminate causing septic arthritis or dermatitis. The infection is a major cause of sexually transmitted disease worldwide and contributes significantly to infertility and neonatal complications. Diagnosis and treatment are critical to prevent long-term sequelae.
Inciting Event
Exposure to infected genital secretions during unprotected vaginal, anal, or oral sex initiates infection.
Direct mucosal contact with Neisseria gonorrhoeae is required for transmission.
Perinatal exposure during childbirth can lead to neonatal conjunctivitis.
Latency Period
Symptoms typically develop within 2 to 7 days after exposure to the bacteria.
Asymptomatic carriage can persist for weeks to months, especially in females.
Disseminated infection may present days to weeks after initial mucosal infection.
Diagnostic Delay
Asymptomatic infections, especially in females, lead to delayed diagnosis due to lack of symptoms.
Misattribution of symptoms to other causes such as urinary tract infection or vaginitis can delay recognition.
Limited access to healthcare or stigma around STIs contributes to delayed testing and treatment.
False-negative results from improper specimen collection or testing methods may delay diagnosis.
Clinical Presentation
Signs & Symptoms
Dysuria and urethral discharge are the most common presenting symptoms in males.
Increased vaginal discharge and intermenstrual bleeding are common in females.
Pelvic pain and cervical motion tenderness may indicate pelvic inflammatory disease.
Arthralgia, tenosynovitis, and dermatitis characterize disseminated gonococcal infection.
Conjunctivitis with purulent discharge can occur from autoinoculation or neonatal infection.
History of Present Illness
Acute onset of purulent urethral discharge and dysuria in males is typical.
Females often report vaginal discharge, intermenstrual bleeding, or pelvic pain but may be asymptomatic.
Rectal infections cause anal pain, discharge, or bleeding, especially in MSM.
Pharyngeal infections are usually asymptomatic or cause mild sore throat.
Disseminated gonococcal infection presents with fever, polyarthralgia, and skin lesions days after mucosal symptoms.
Past Medical History
History of prior STIs increases susceptibility to gonorrhea due to mucosal disruption.
Previous antibiotic treatment may alter clinical presentation or lead to resistant strains.
Use of immunosuppressive medications can increase risk of disseminated infection.
Contraceptive methods that do not protect against STIs, such as oral contraceptives, may be relevant.
Family History
[]
Physical Exam Findings
Purulent urethral discharge in males is a hallmark finding of gonorrhea infection.
Cervical mucopurulent discharge and friability are common findings on pelvic exam in infected females.
Erythema and swelling of the urethral meatus or cervix may be present.
Tenderness over the epididymis or testis can indicate epididymitis secondary to gonorrhea.
Conjunctival injection with purulent discharge may be seen in gonococcal conjunctivitis.
Diagnostic Workup
Diagnostic Criteria
Diagnosis of gonorrhea is established by detecting Neisseria gonorrhoeae from clinical specimens using nucleic acid amplification tests (NAATs), which are the gold standard due to their high sensitivity and specificity. Specimens are typically collected from the urethra, cervix, rectum, or pharynx depending on exposure history. Gram stain of urethral discharge showing intracellular gram-negative diplococci can provide rapid presumptive diagnosis in symptomatic men. Culture remains important for antibiotic susceptibility testing. Positive NAAT or culture confirms the diagnosis.
Pathophysiology
Key Mechanisms
Attachment of Neisseria gonorrhoeae to mucosal epithelial cells via pili and outer membrane proteins initiates infection.
Endocytosis and invasion of epithelial cells allow bacterial survival and replication within host tissues.
Inflammatory response triggered by bacterial endotoxins and immune activation causes mucosal damage and symptoms.
Antigenic variation of pili and surface proteins enables immune evasion and persistent infection.
Complement resistance mediated by bacterial surface proteins promotes survival in the bloodstream and dissemination.
| Involvement | Details |
|---|---|
| Organs | Urethra is commonly infected in males, causing dysuria and purulent discharge. |
Cervix is the primary site of infection in females, often asymptomatic but can cause cervicitis. | |
Pharynx can harbor asymptomatic infection following oral exposure to Neisseria gonorrhoeae. | |
| Tissues | Urogenital mucosa is the primary site of Neisseria gonorrhoeae colonization and inflammation. |
Conjunctival tissue can be involved in neonatal gonococcal ophthalmia leading to purulent conjunctivitis. | |
Rectal mucosa may be affected in cases of receptive anal intercourse, causing proctitis. | |
| Cells | Neutrophils are the primary immune cells that phagocytose Neisseria gonorrhoeae and mediate acute inflammation. |
Macrophages contribute to bacterial clearance and antigen presentation during infection. | |
Epithelial cells of the mucosa serve as the initial site of bacterial adherence and invasion. | |
| Chemical Mediators | Interleukin-8 (IL-8) is secreted by infected epithelial cells to recruit neutrophils to the site of infection. |
Tumor necrosis factor-alpha (TNF-α) promotes local inflammation and tissue damage in infected mucosa. | |
Lipooligosaccharide (LOS) from Neisseria gonorrhoeae acts as an endotoxin triggering host immune responses. |
Treatments
Pharmacological Treatments
Ceftriaxone
- Mechanism:
Binds to penicillin-binding proteins to inhibit bacterial cell wall synthesis, leading to bacterial lysis.
- Side effects:
Allergic reactions
Gastrointestinal upset
Injection site reactions
- Clinical role:
First-line
Azithromycin
- Mechanism:
Inhibits bacterial 50S ribosomal subunit, blocking protein synthesis.
- Side effects:
Gastrointestinal upset
QT prolongation
Allergic reactions
- Clinical role:
Adjunctive
Non-pharmacological Treatments
Counseling on safe sexual practices to prevent reinfection and transmission.
Notification and treatment of sexual partners to control spread of gonorrhea.
Regular screening in high-risk populations to detect asymptomatic infections.
Prevention
Pharmacological Prevention
Dual therapy with ceftriaxone and azithromycin is recommended to treat and prevent resistance.
Post-exposure prophylaxis with antibiotics is not routinely recommended but may be considered in high-risk exposures.
Routine screening and early treatment reduce transmission and complications.
Treatment of sexual partners is essential to prevent reinfection and spread.
No vaccine is currently available, so pharmacological prevention focuses on treatment.
Non-pharmacological Prevention
Consistent condom use significantly reduces transmission risk of gonorrhea.
Regular screening of sexually active individuals helps identify asymptomatic infections early.
Partner notification and treatment prevent reinfection and community spread.
Abstinence or reduction of number of sexual partners lowers exposure risk.
Education on safe sexual practices is critical for prevention.
Outcome & Complications
Complications
Pelvic inflammatory disease (PID) can lead to infertility and chronic pelvic pain.
Disseminated gonococcal infection (DGI) causes septic arthritis, tenosynovitis, and dermatitis.
Epididymitis in males can result in testicular pain and potential infertility.
Neonatal conjunctivitis (ophthalmia neonatorum) can cause blindness if untreated.
Increased risk of HIV transmission due to mucosal inflammation and ulceration.
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Gonorrhea (Neisseria gonorrhoeae) versus Chlamydia trachomatis infection
Gonorrhea (Neisseria gonorrhoeae) | Chlamydia trachomatis infection |
|---|---|
Gram-negative diplococcus with a thick peptidoglycan layer | Intracellular gram-negative bacteria lacking a peptidoglycan cell wall |
NAAT positive for Neisseria gonorrhoeae | Nucleic acid amplification test (NAAT) positive for Chlamydia trachomatis |
More likely to cause purulent discharge and symptomatic urethritis | Often asymptomatic or mild symptoms, especially in women |
Gonorrhea (Neisseria gonorrhoeae) versus Trichomoniasis
Gonorrhea (Neisseria gonorrhoeae) | Trichomoniasis |
|---|---|
Gram-negative diplococcus seen on Gram stain | Motile protozoan parasite detected on wet mount microscopy |
Gram stain shows many polymorphonuclear leukocytes with intracellular diplococci | Wet mount shows motile trichomonads and increased vaginal pH (>4.5) |
Purulent urethral or cervical discharge without frothiness | Frothy, malodorous vaginal discharge with vulvovaginal irritation |
Gonorrhea (Neisseria gonorrhoeae) versus Bacterial vaginosis
Gonorrhea (Neisseria gonorrhoeae) | Bacterial vaginosis |
|---|---|
Gram stain shows intracellular gram-negative diplococci | Clue cells on wet mount and positive whiff test |
Purulent discharge with marked inflammation | Thin, gray vaginal discharge with fishy odor, usually no inflammation |
Positive culture or NAAT for Neisseria gonorrhoeae | Positive amine odor test and decreased vaginal lactobacilli |
Gonorrhea (Neisseria gonorrhoeae) versus Herpes simplex virus (HSV) infection
Gonorrhea (Neisseria gonorrhoeae) | Herpes simplex virus (HSV) infection |
|---|---|
Purulent urethritis or cervicitis without vesicles | Painful vesicular genital lesions with recurrent episodes |
NAAT positive for Neisseria gonorrhoeae | PCR or viral culture positive for HSV DNA |
Gram stain shows intracellular gram-negative diplococci | Tzanck smear shows multinucleated giant cells |
Gonorrhea (Neisseria gonorrhoeae) versus Mycoplasma genitalium infection
Gonorrhea (Neisseria gonorrhoeae) | Mycoplasma genitalium infection |
|---|---|
Gram-negative diplococcus visible on Gram stain | Lacks a cell wall, not visible on Gram stain |
NAAT positive for Neisseria gonorrhoeae | NAAT positive for Mycoplasma genitalium |
Usually responds to first-line antibiotics targeting Neisseria gonorrhoeae | Often causes persistent or recurrent urethritis despite standard treatment |